Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Hong Kong Perspective: Should Older Age Influence Hepatitis B Treatment Decisions?

Older age is more a state of mind than a biological definition. We should be proactive in monitoring and treating all patients with chronic hepatitis B, regardless of age. Listen as Dr George Lau discusses these and other issues in HBV management.
George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA)
Released: December 15, 2022

When it comes to managing adults with HBV, should age factor into your treatment decision—or is it important to treat everyone, regardless of age?

Listen as Dr George Lau discusses these questions and more for strategizing the monitoring and treatment of older adults with HBV.

Information on this Educational Activity

Faculty

George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA)

Chairman
Humanity and Health Medical Group
Hong Kong, China
Chair, Professor,
and Co-Director
Liver Diseases & Transplant Centre
The Fifth Medical Centre of Chinese PLA General Hospital,
Beijing, China

George Lau, MBBS (HKU), MD (HKU), FRCP (Edin, Lond), FAASLD (USA), has no relevant financial relationships to disclose.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings